Cart
sales@molnova.com
Trichostatin A (TSA)
CAS No. 58880-19-6
Trichostatin A (TSA)( (TSA) )
Catalog No. M15172 CAS No. 58880-19-6
Trichostatin A (TSA) is an HDAC inhibitor with IC50 of ~1.8 nM – HDAC8 is the only known member of the HDAC-family that is not affected by TSA.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 174 | In Stock |
|
| 2MG | 106 | In Stock |
|
| 5MG | 187 | In Stock |
|
| 10MG | 354 | In Stock |
|
| 25MG | 496 | In Stock |
|
| 50MG | 702 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTrichostatin A (TSA)
-
NoteResearch use only, not for human use.
-
Brief DescriptionTrichostatin A (TSA) is an HDAC inhibitor with IC50 of ~1.8 nM – HDAC8 is the only known member of the HDAC-family that is not affected by TSA.
-
DescriptionTrichostatin A (TSA) is an HDAC inhibitor with IC50 of ~1.8 nM – HDAC8 is the only known member of the HDAC-family that is not affected by TSA.
-
In Vitro——
-
In Vivo——
-
Synonyms(TSA)
-
PathwayCell Cycle/DNA Damage
-
TargetHDAC
-
RecptorHDAC
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number58880-19-6
-
Formula Weight302.4
-
Molecular FormulaC17H22N2O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:23 mg/mL (76.05 mM); Ethanol:<1 mg/mL (<1 mM); Water:<1 mg/mL (<1 mM)
-
SMILESC[C@H](/C=C(\C)/C=C/C(=O)NO)C(=O)C1=CC=C(C=C1)N(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Vigushin DM, et al. Clin Y Res, 2001, 7(4), 971-976.
molnova catalog
related products
-
BRD4354
BRD4354 is a moderately potent, selective, reversible inhibitor of HDAC5 and HDAC9 with IC50 of 0.85 uM and 1.88 uM.
-
Exifone
Exifone is a mixed, nonessential activator of HDAC1 that is capable of binding to both free and substrate-bound enzyme, resulting in an increased relative maximal rate of HDAC1-catalyzed deacetylation.
-
Encorafenib
LGX818 is an orally available mutated BRaf V600E inhibitor(IC50=0.3 nM) with potential antineoplastic activity.
